Intrexon
| |
Traded as |
NYSE: XON Russell 2000 Component |
---|---|
Industry | Biotechnology |
Founded | May 21, 1998 |
Website |
dna |
Intrexon Corporation (NYSE: XON) is an American biotechnology company, and its chairman and CEO is Randal J. Kirk.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland.[1][2] With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.[3]
History
In 2015, Intrexon purchased Oxitec, a maker of gene drive technology for $160 million.[4]
References
- ↑ "Intrexon Corporation: Private Company Information". Bloomberg. Retrieved 2017-06-26.
- ↑ "Intrexon Corp (XON) Company Profile". Reuters.com. Retrieved 2017-06-26.
- ↑ "FAQ | Intrexon". Intrexon InvestorRoom. Retrieved 2018-03-28.
- ↑ Nickel, Rod (15 September 2015). "Market turbulence or not, North American investors plow into farm tech". Reuters. Retrieved 9 October 2015.
External links
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.